Search alternatives:
significant benefits » significant effects (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
significant benefits » significant effects (Expand Search)
significant based » significant cause (Expand Search), significant barrier (Expand Search), significant burden (Expand Search)
based decrease » caused decreased (Expand Search), marked decrease (Expand Search), based defense (Expand Search)
-
1
-
2
-
3
-
4
Interaction analysis of sex and age in the adjusted Cox model based on age cutoff of 50.
Published 2025Subjects: -
5
Survival curves for female and male based on unadjusted (A) and adjusted (B) Cox model.
Published 2025Subjects: -
6
-
7
Survival curves for different sex and age groups based on unadjusted (A) and adjusted (B) Cox model.
Published 2025Subjects: -
8
-
9
Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
10
Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
11
Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf
Published 2025“…No added benefit of addition of ruxolitinib is observed on the significant improvement in the urine albumin/creatinine ratio and the anti-dsDNA IgG levels induced by UCB-Tregs.…”
-
12
-
13
-
14
-
15
-
16
-
17
Statistically significant linear increase in use of antidepressants during the observed time period.
Published 2025Subjects: -
18
-
19
-
20